Revalesio is founded in 2006, operates from its headquarter in 1202 East D Street Tacoma, Washington 98421, US. The company operates in the Manufacturing, Pharmaceuticals sector.
Revalesio specializes in Cellular imbalance correction, Mitochondrial dysfunction treatment, Immune response modulation, Neuron protection, Biomedical research collaboration, and offers services including Therapies for neurological diseases, Treatments for chronic neurological diseases, and Improvements in recovery from acute neurological injury.
Total Rounds
US$ 14M
Last Round
US$ 14M
Rounds
1